Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebocontrolled trial - Cherney, DZ I; Zinman, B; Inzucchi, S E (Lancet Diabetes Endocrinol, 2017)